Tri-Cities Gastroenterology

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials
• Colorectal cancer1 trial
• Crohn's disease1 trial
• Irritable bowel syndrome1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• CinPhloro Pharma, LLC1 trial
• Cristcot HCA LLC1 trial
• Eli Lilly and Company1 trial
• Guardant Health, Inc.1 trial
• Takeda1 trial

Running trials

• Recruiting

  A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  NCT06581328· Phase 4· Takeda· Source

  Contact: Stephen Fry (principal investigator)

• Active, not recruiting

  Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

  NCT04136002· Guardant Health, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Completed

  A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05767021· Phase 3· Eli Lilly and Company· Source

• Completed

  Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

  NCT04469686· Phase 3· Cristcot HCA LLC· Source